 |
|
|
| |
Quantification of plasma HDV RNA by three commercially available assays in untreated and Bulevirtide-treated real-life
patients with CHD: Robogene 2.0 vs. Altostar vs. Eurobioplex EBX071
|
| |
| |
EASL 2025 May 7-10 Amsterdam
M.P. Anolli1,2,3, S Uceda Renteria4, E. Degasperi1,2, F. Facchetti1, D. Sambarino1, M. Borghi1, R. Perbellini1,
R. Soffredini1, S. Monico1, A. Callegaro4, P. Lampertico1,2,3
1Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy; 2D-SOLVE consortium, an EU Horizon Europe funded project (No 101057917), Hannover, Germany; 3CRC "A. M. and A. Migliavacca" Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
4Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Virology Unit, Milan, Italy
|
| |
|
|
|
|
|
